Comment on Bisson et al. Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. <i>J. Mol. Pathol.</i> 2024, <i>5</i>, 1–10 by Emina Torlakovic, Nicola Normanno

Get full text

Liquid biopsies, are we ready for prime time? by Nicola Normanno, Mark Stewart, Kathi Apostolidis

Get full text

cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation? by Nicola Normanno, Antonella De Luca, Francesco Perrone

Get full text

Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy by Marianeve Carotenuto, Alessandra Sacco, Laura Forgione, Nicola Normanno

Get full text

Resistance to immune checkpoint inhibitors in colorectal cancer with deficient mismatch repair/microsatellite instability: misdiagnosis, pseudoprogression and/or tumor heterogeneit... by Nicola Normanno, Vincenza Caridi, Matteo Fassan, Antonio Avallone, Fortunato Ciardiello, Carmine Pinto

Get full text

Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma by Anna Maria Rachiglio, Alessandra Sacco, Laura Forgione, Claudia Esposito, Nicoletta Chicchinelli, Nicola Normanno

Get full text

KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting. by Carlo Barone, Carmine Pinto, Nicola Normanno, Lorenzo Capussotti, Francesco Cognetti, Alfredo Falcone, Lorenzo Mantovani

Get full text

Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative by Nicola Normanno, Paolo Chiodini, Riziero Esposito Abate, Raffaella Pasquale, Alessandra Sacco, Vittorio Simeon, Monica Rosaria Maiello, Daniela Frezzetti

Get full text

Bioinformatics: From NGS Data to Biological Complexity in Variant Detection and Oncological Clinical Practice by Serena Dotolo, Riziero Esposito Abate, Cristin Roma, Davide Guido, Alessia Preziosi, Beatrice Tropea, Fernando Palluzzi, Luciano Giacò, Nicola Normanno

Get full text

Cetuximab in first line treatment of metastatic colorectal cancer by Carlo Barone, Andrea Belisari, Fortunato Ciardiello, Lorenzo Mantovani, Lucia D’Angiolella, Gianluca Furneri, Nicola Normanno, Patrizio Piacentini, Carmine Pinto

Get full text

Lurbinectedin in small cell lung cancer by Anna Manzo, Vincenzo Sforza, Guido Carillio, Giuliano Palumbo, Agnese Montanino, Claudia Sandomenico, Raffaele Costanzo, Giovanna Esposito, Francesca Laudato, Edoardo Mercadante, Carmine La Manna, Paolo Muto, Giuseppe Totaro, Rossella De Cecio, Carmine Picone, Maria Carmela Piccirillo, Giacomo Pascarella, Nicola Normanno, Nicola Normanno, Alessandro Morabito

Get full text

Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line. by Giuseppe Pirozzi, Virginia Tirino, Rosa Camerlingo, Renato Franco, Aantonello La Rocca, Eleonora Liguori, Nicola Martucci, Francesca Paino, Nicola Normanno, Gaetano Rocco

Get full text

Immune checkpoint inhibitor treatment in patients with oncogene-addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion by Nicola Normanno, Matthias Preusser, Julien Mazières, Anna S. Berghoff, Beatriz Bellosillo, Christophe Caux, Adrianus de Langen, Mariano Provencio, Federico Rojo, Jurgen Wolf

Get full text

KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment. by Nicola Normanno, Carmine Pinto, Francesca Castiglione, Alberto Bardelli, Marcello Gambacorta, Gerardo Botti, Oscar Nappi, Salvatore Siena, Fortunato Ciardiello, Gianluigi Taddei, Antonio Marchetti

Get full text

Electrochemical detection of miRNA using commercial and hand‐made screen‐printed electrodes: liquid biopsy for cancer management as case of study by Ada Raucci, Wanda Cimmino, Dr. Sabrina Romanò, Dr. Sima Singh, Prof. Dr. Nicola Normanno, Prof. Dr. Federico Polo, Prof. Dr. Stefano Cinti

Get full text

Machine Learning and Radiomics Analysis for Tumor Budding Prediction in Colorectal Liver Metastases Magnetic Resonance Imaging Assessment by Vincenza Granata, Roberta Fusco, Maria Chiara Brunese, Gerardo Ferrara, Fabiana Tatangelo, Alessandro Ottaiano, Antonio Avallone, Vittorio Miele, Nicola Normanno, Francesco Izzo, Antonella Petrillo

Get full text

CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCR... by Stefania Napolitano, Giulia Martini, Davide Ciardiello, Davide Ciardiello, Massimo Di Maio, Nicola Normanno, Antonio Avallone, Erika Martinelli, Evaristo Maiello, Teresa Troiani, Fortunato Ciardiello

Get full text

Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome. by Massimo Pancione, Lina Sabatino, Alessandra Fucci, Vincenzo Carafa, Angela Nebbioso, Nicola Forte, Antonio Febbraro, Domenico Parente, Concetta Ambrosino, Nicola Normanno, Lucia Altucci, Vittorio Colantuoni

Get full text

Correction: Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome. by Massimo Pancione, Lina Sabatino, Alessandra Fucci, Vincenzo Carafa, Angela Nebbioso, Nicola Forte, Antonio Febbraro, Domenico Parente, Concetta Ambrosino, Nicola Normanno, Lucia Altucci, Vittorio Colantuoni

Get full text

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC... by Angela Damato, Francesco Iachetta, Lorenzo Antonuzzo, Guglielmo Nasti, Francesca Bergamo, Roberto Bordonaro, Evaristo Maiello, Alberto Zaniboni, Giuseppe Tonini, Alessandra Romagnani, Annalisa Berselli, Nicola Normanno, Carmine Pinto

Get full text